Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

• Main Authors: Himanshu P. Upadhyaya (Author), Lesley M. Arnold (Author), Karla Alaka (Author), Meihua Qiao (Author), David Williams (Author), Renata Mehta (Author)
• Format: Book
• Published: BMC, 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. Methods In this Phase 3b, multisite (US, Argentina, Puerto Rico, and...